Willner & Heller, LLC Bristol Myers Squibb CO Transaction History

Willner & Heller, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$40.25 - $52.99 $117,208 - $154,306	-2,912 Reduced 32.2%	6,131 $254,000
Q1 2024 Jul 19, 2024	BUY	$47.98 - $54.4 $145,139 - $164,560	3,025 Added 50.27%	9,043 $490,000
Q4 2023 Mar 06, 2024	BUY	$48.48 - $57.85 $291,752 - $348,141	6,018 New	6,018 $308,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Willner & Heller, LLC, based on Form 13F filings with the SEC.

Stay updated on Willner & Heller, LLC with notifications on news.